NCT04403087View on ClinicalTrials.gov

Trimebutine on the Development of Adverse Events Related to the Helicobacter Pylori Eradication Medications

PHASE4CompletedINTERVENTIONAL

Enrollment

132

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

June 1, 2021

Study Completion Date

July 1, 2021

Conditions

Helicobacter Pylori Infection

Interventions

DRUG

Trimebutine 100 MG

Trimebutine 100mg three times a day

Trial Locations (1)

24253

Chuncheon Sacred Heart hospital, Chuncheon

All Listed Sponsors

lead

Chuncheon Sacred Heart Hospital

OTHER